HC Wainwright Issues Pessimistic Outlook for AMPX Earnings

Amprius Technologies, Inc. (NYSE:AMPXFree Report) – HC Wainwright reduced their FY2028 earnings per share (EPS) estimates for Amprius Technologies in a note issued to investors on Thursday, August 6th. HC Wainwright analyst A. Dayal now expects that the company will post earnings of $0.16 per share for the year, down from their prior forecast of $0.18. The consensus estimate for Amprius Technologies’ current full-year earnings is ($0.08) per share.

Other equities analysts have also issued research reports about the company. JonesTrading started coverage on Amprius Technologies in a research note on Friday, July 10th. They set a “buy” rating and a $30.00 target price on the stock. Zacks Research raised Amprius Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Northland Securities set a $24.00 price target on shares of Amprius Technologies in a research report on Monday, May 11th. Wall Street Zen cut shares of Amprius Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Finally, Clear Str began coverage on shares of Amprius Technologies in a research note on Tuesday, June 2nd. They issued a “strong-buy” rating and a $33.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Amprius Technologies has an average rating of “Moderate Buy” and a consensus price target of $22.50.

Read Our Latest Analysis on AMPX

Amprius Technologies Trading Down 4.5%

Shares of NYSE AMPX opened at $11.20 on Friday. The stock has a market capitalization of $1.59 billion, a PE ratio of -38.61 and a beta of 2.33. Amprius Technologies has a twelve month low of $6.36 and a twelve month high of $24.23. The stock has a fifty day simple moving average of $13.65 and a 200-day simple moving average of $14.93.

Amprius Technologies (NYSE:AMPXGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Amprius Technologies had a negative return on equity of 13.23% and a negative net margin of 35.16%.The firm had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million.

Hedge Funds Weigh In On Amprius Technologies

Several hedge funds and other institutional investors have recently made changes to their positions in AMPX. Oppenheimer & Co. Inc. grew its holdings in Amprius Technologies by 47.7% during the 4th quarter. Oppenheimer & Co. Inc. now owns 442,090 shares of the company’s stock worth $3,488,000 after acquiring an additional 142,751 shares in the last quarter. Stephens Investment Management Group LLC raised its holdings in shares of Amprius Technologies by 33.1% in the 4th quarter. Stephens Investment Management Group LLC now owns 1,441,698 shares of the company’s stock valued at $11,375,000 after purchasing an additional 358,791 shares in the last quarter. Hussman Strategic Advisors Inc. acquired a new stake in shares of Amprius Technologies in the 4th quarter valued at $1,657,000. Vanguard Group Inc. lifted its position in shares of Amprius Technologies by 9.5% during the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock worth $56,245,000 after purchasing an additional 616,037 shares during the last quarter. Finally, UBS Group AG lifted its position in shares of Amprius Technologies by 35.5% during the 4th quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock worth $16,561,000 after purchasing an additional 549,892 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company’s stock.

Insider Buying and Selling

In other news, CEO Thomas M. Stepien sold 2,000 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $20.97, for a total value of $41,940.00. Following the sale, the chief executive officer directly owned 625,625 shares in the company, valued at approximately $13,119,356.25. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Donald R. Dixon sold 85,000 shares of Amprius Technologies stock in a transaction on Monday, June 15th. The shares were sold at an average price of $17.17, for a total value of $1,459,450.00. Following the completion of the transaction, the director owned 359,380 shares of the company’s stock, valued at approximately $6,170,554.60. This trade represents a 19.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 310,144 shares of company stock valued at $5,049,997 in the last three months. 5.10% of the stock is currently owned by insiders.

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Record Q2 revenue reached approximately $34 million, representing 125% year-over-year growth and exceeding expectations. Management also raised its outlook, forecasting at least $140 million in 2026 revenue and a gross margin of at least 28%. Amprius forecasts 2026 revenue and gross margin
  • Positive Sentiment: Demand for Amprius’ SiCore batteries is expanding, particularly in defense drones. The company is also increasing NDAA-compliant manufacturing capacity, improving its ability to pursue U.S. defense-related contracts. Q2 earnings call highlights
  • Positive Sentiment: Coverage has improved after Zacks Research upgraded AMPX from “strong sell” to “hold.” Reports also cited bullish analyst targets, increased institutional buying and elevated short interest, which could amplify a rebound if operating results continue to improve. Zacks Research
  • Neutral Sentiment: The earnings release produced a revenue beat and prompted a sharp initial rally, but the stock’s subsequent volatility suggests investors may be taking profits or demanding more evidence that the upgraded guidance is achievable. Amprius trading after earnings beat
  • Negative Sentiment: Amprius remains unprofitable, with a quarterly loss and negative margins. Continued cash needs, production scale-up requirements and dependence on converting battery demand into contracts could limit the stock’s upside despite the strong growth outlook. Amprius Q2 earnings report

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Recommended Stories

Earnings History and Estimates for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.